Kopp Investment Advisors LLC 13F 持仓 · 最近申报 2019年Q3
Kopp Investment Advisors 在 2019年Q3（报告期截至 2019-09-30）的 SEC 13F 申报中报告了 45 只证券，申报市值合计 5,441.80 万美元。前几大持仓：NEO（7.30%）、PODD（7.25%）、TWLO（6.92%）。本季前 25 大持仓中：减持 22 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | NEO | NeoGenomics Inc. | $4.0M | 7.30% | 207,781 | 减持 |
| 2 | PODD | Insulet Corp. | $3.9M | 7.25% | 23,934 | 减持 |
| 3 | TWLO | Twilio, Inc. Class A | $3.8M | 6.92% | 34,263 | 减持 |
| 4 | CY | Cypress Semiconductor Corp. | $3.7M | 6.84% | 159,460 | 减持 |
| 5 | VCEL | Vericel Corp. | $3.0M | 5.52% | 198,445 | 减持 |
| 6 | HZNP | Horizon Therapeutics Pub Ltd. | $2.8M | 5.23% | 104,462 | 减持 |
| 7 | UPLD | Upland Software, Inc. | $2.5M | 4.52% | 70,535 | 减持 |
| 8 | FIVN | Five9, Inc. | $2.4M | 4.38% | 44,400 | 减持 |
| 9 | CYBR | CyberArk Software Ltd. | $2.3M | 4.23% | 23,044 | 减持 |
| 10 | OMCL | Omnicell Inc. | $2.2M | 4.07% | 30,617 | 减持 |
| 11 | ATRC | AtriCure Inc. | $2.2M | 4.02% | 87,809 | 减持 |
| 12 | MXL | MaxLinear, Inc. | $2.0M | 3.67% | 89,316 | 减持 |
| 13 | SUPN | Supernus Pharmaceuticals, Inc. | $1.4M | 2.50% | 49,462 | 减持 |
| 14 | SPY | SPDR S&P 500 ETF TR | $1.2M | 2.26% | 4,150 | 减持 |
| 15 | SRGA | RTI Surgical Inc. | $1.2M | 2.18% | 415,577 | 减持 |
| 16 | CVLT | CommVault Systems Inc. | $1.2M | 2.13% | 25,962 | 减持 |
| 17 | XENT | Intersect ENT Inc. | $1.1M | 2.11% | 67,390 | 减持 |
| 18 | LGND | Ligand Pharmaceuticals Inc | $1.1M | 1.94% | 10,578 | 减持 |
| 19 | AAPL | Apple Inc. | $1.0M | 1.85% | 4,494 | 持平 |
| 20 | PG | Procter & Gamble | $671,000 | 1.23% | 5,394 | 减持 |
| 21 | QQQ | Invesco QQQ Trust | $647,000 | 1.19% | 3,425 | 持平 |
| 22 | AFL | Aflac Inc. | $622,000 | 1.14% | 11,895 | 减持 |
| 23 | MAR | Marriott Intl. Inc. | $608,000 | 1.12% | 4,888 | 减持 |
| 24 | JPM | JP Morgan Chase & Co. | $594,000 | 1.09% | 5,049 | 减持 |
| 25 | VTI | Vanguard Index FDS | $574,000 | 1.05% | 3,800 | 持平 |
来源：SEC 13F 申报文件 · 截至 2019-09-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR